1. European Medicines Agency . COVID-19 vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets, 2021. Available: https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots [Accessed 8 Apr 2021].
2. Reported orofacial adverse effects of COVID-19 vaccines: the knowns and the unknowns;Cirillo;J Oral Pathol Med,2021
3. Public Assessment Report - COVID-19 Vaccine Moderna, 0.20 mg/mL dispersion for injection, 2021. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/962920/Public_Assessment_Report_for_Moderna_COVID-19_vaccine.pdf [Accessed 8 Apr 2021].
4. MHRA . Public Assessment Report COVID-19 Vaccine AstraZeneca, solution for injection in multidose container COVID-19 Vaccine (ChAdOx1-S [recombinant]), 2021. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/963928/UKPAR_COVID_19_Vaccine_AstraZeneca_23.02.2021.pdf [Accessed 8 April 2021].
5. GOV.UK . Information for UK recipients on Pfizer/BioNTech COVID-19 vaccine [Internet], 2021. Available: https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-uk-recipients-on-pfizerbiontech-covid-19-vaccine [Accessed 8 Apr 2021].